| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | CA2431179A1 Synthesis of small particles |
| 06/13/2002 | CA2431166A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2430989A1 Method of collecting placental stem cells |
| 06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430847A1 1, 2, 4-oxadiazole derivatives as hppar alpha agonists |
| 06/13/2002 | CA2430846A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | CA2430769A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430524A1 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | CA2430412A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | CA2429728A1 Tyrosine kinase inhibitors |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2428208A1 Lipid-associated molecules |
| 06/13/2002 | CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | CA2426988A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/12/2002 | EP1213296A1 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1213287A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/12/2002 | EP1213032A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/12/2002 | EP1213021A1 Remedies for diabetes |
| 06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
| 06/12/2002 | EP1213014A2 Process and system for controlled-release drug delivery |
| 06/12/2002 | EP1212941A2 Modulating ramp activity |
| 06/12/2002 | EP1212601A1 Glucose biosensor |
| 06/12/2002 | EP1212456A1 Antisense modulation of shp-2 expression |
| 06/12/2002 | EP1212416A2 Nucleic acid based modulators of gene expression |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212335A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212322A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212309A1 Caspase inhibitor |
| 06/12/2002 | EP1212305A2 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212295A1 SUBSTITUTED $g(a)-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212086A1 Immunological tolerance-induction agent |
| 06/12/2002 | EP1212081A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/12/2002 | EP1212077A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 06/12/2002 | EP1212071A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/12/2002 | EP1212065A1 Compositions and methods for raising hdl cholesterol levels |
| 06/12/2002 | EP1212059A1 Iron chelators and uses thereof |
| 06/12/2002 | EP1212055A1 Neurotherapeutic composition and method |
| 06/12/2002 | EP1082107A4 Controlled release lipoic acid |
| 06/12/2002 | EP1028947B1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0808314B1 Forms of paroxetin hydrochloride |
| 06/12/2002 | EP0807185B1 Antitumor preparations containing a lipoteichoic acid from steptococcus |
| 06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
| 06/12/2002 | EP0737200B1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 06/12/2002 | EP0717625B1 A method of treating liver disease and like indications with vasodilating agents |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | EP0666753B9 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353710A 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353694A Alpha-substituted carboxylic acid derivatives |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353603A Method of controlling weight gain associated with therapeutic drugs |
| 06/12/2002 | CN1352937A Dispersed calcium carbonate-xylitol solid and chewing compound calcium carbonate tablet |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403657 Citalopram and phenteramine |
| 06/11/2002 | US6403641 Treating a human for obesity comprises administering to the patient a compound of formula n-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-n,n-dimethy lamine or a salt and an oxetane compound |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403624 8,8A-dihydroindeno[1,2-D] thiazole derivatives which are substituted in the 8A-position; processes for their preparation and their use as medicaments |
| 06/11/2002 | US6403615 Treats osteoporosis, hyperlipidemia, and cardiovascular disorders associated with menopause; side effect reduction compared to estrogen-replacement therapy |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403345 Culturing, fermentation, obtaining biomass; purification; foods, drugs, cosmetics |
| 06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | CA2262692C Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/06/2002 | WO2002044397A1 Process for producing substance positive in elson-morgan reaction and use thereof |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044367A1 Method of screening remedy for diabetes |